The benefits of CBD and other non-THC cannabinoids don’t stop there. Terpenes and the wide spectrum of other chemical compounds found in hemp flower-bud extracts provide potent anti-inflammatory and antioxidant properties. And like most other herbs, hemp flower-bud extracts have been associated with antimicrobial properties, though cannabis doesn’t appear to be as strong an antimicrobial as many other herbs.
Previously, I had reviewed hemp-based beauty topicals and THC beauty products pioneering the way for cannabis in the skincare industry. This time, I tested the diverse range of CBD oil-based beauty products, which are both potent and legally available for shipping to most states. This is the new frontier in skincare—and these companies are paving the way. Go support them before Sephora hears about this.
Cannabidiol, a non-euphoriant phytocannabinoid common in certain strains, shares neuroprotective effects with THC, inhibits glutamate neurotoxicity, and displays antioxidant activity greater than ascorbic acid (vitamin C) or tocopherol (vitamin E) (Hampson et al 1998). While THC has no activity at vanilloid receptors, CBD, like AEA, is a TRPV1 agonist that inhibits fatty acid amidohydrolase (FAAH), AEA’s hydrolytic enzyme, and also weakly inhibits AEA reuptake (Bisogno et al 2001). These activities reinforce the conception of CBD as an endocannabinoid modulator, the first clinically available (Russo and Guy 2006). CBD additionally affects THC function by inhibiting first pass hepatic metabolism to the possibly more psychoactive 11-hydroxy-THC, prolonging its half-life, and reducing associated intoxication, panic, anxiety and tachycardia (Russo and Guy 2006). Additionally, CBD is able to inhibit tumor necrosis factor-alpha (TNF-α) in its own right in a rodent model of rheumatoid arthritis (Malfait et al 2000). At a time when great concern is accruing in relation to NSAIDs in relation to COX-1 inhibition (gastrointestinal ulcers and bleeding) and COX-2 inhibition (myocardial infarction and cerebrovascular accidents), CBD, like THC, inhibits neither enzyme at pharmacologically relevant doses (Stott et al 2005a). A new explanation of inflammatory and analgesic effects of CBD has recently come to light with the discovery that it is able to promote signaling of the adenosine receptor A2A by inhibiting the adenosine transporter (Carrier et al 2006).
Scott Shannon, M.D., assistant clinical professor at the University of Colorado, recently sifted through patient charts from his four-doctor practice to document CBD’s effects on anxiety. His study, as yet unpublished, found “a fairly rapid decrease in anxiety scores that appears to persist for months,” he says. But he says he can’t discount a placebo effect, especially since “there’s a lot of hype right now.”
© 2018 Meredith Corporation Travel & Leisure Group. All rights reserved. TravelandLeisure.com is part of the Travel & Leisure Group. Travel + Leisure is a trademark of Meredith Corporation Travel & Leisure Group, registered in the United States and other countries. Travel + Leisure may receive compensation for some links to products and services on this website. Offers may be subject to change without notice. | EU Data Subject Requests
). Hempseed oil is very rich in PUFAs ( polyunsaturated fatty acids ) which have been noted to be extremely healthy and strongly anti-inflammatory. Within about 20 weeks, the plasma lipid profiles of patients changed considerably. Their blood now contained more of healthy fats, which was doing their skin good. Omega – 3 and omega – 6 fatty acids in hempseed oil were responsible for such an effect.
Contrary to popular opinion, the external application is not the only way by which CBD oil can be consumed. By placing it under the tongue, many consume CBD oil directly. CBD oil has also been innovatively infused into products such as moisturizers and topical creams. CBD oil is an acceptable food supplement, serving as an addendum to cookies, brownies or even tacos! CBD oil capsules are a means by which they can be ingested.
It is for this reason that all the finished hemp goods that you see for sale in America, from food products to clothing to building materials, are part of an imported hemp industry that has surpassed $688 million annually. The size of this import industry is one of the major catalysts for hemp legalization in the U.S. As a renewable source of a range of products, hemp provides an exciting new step in American agriculture.
CBD creams are produced with the extracted oils from cannabis or hemp infused into a topical base. They act upon the body’s naturally occurring CB2 receptors by binding with these components. The CB2 receptors are activated by either the body’s own, already present endocannabinoid system (ECS), or through the presence of phytocannabinoids, which are typically in the form of either CBD or THC.
While very few clinical trials have explored the pain-relieving effects of CBD oil, a report published in the Cochrane Database of Systematic Reviews in 2018 examined the use of a variety of cannabis-based medicines and found they might be of some benefit in the treatment of chronic neuropathic pain. A type of pain triggered by damage to the somatosensory system (i.e., the system responsible for processing sensory stimuli), neuropathic pain often occurs in people with conditions like diabetes and multiple sclerosis.
The FDA has approved Epidiolex, which contains a purified drug substance cannabidiol, one of more than 80 active chemicals in marijuana, for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. That means the FDA has concluded that this particular drug product is safe and effective for its intended indication.
Depression is a common effect of chronic pain. When a person finds it impossible walk or go to work in the morning, it can have devastating effects on normal life. In addition to easing pain, CBD also triggers the release of serotonin and other “happy” chemicals in the body and numbs down brain receptors that contribute to lowly feelings of depression.
In the United States, we're in the middle of a cannabis revolution. Our nation is slowly waking up to the truth that cannabis, what was once dubiously considered a dangerous psychoactive substance, is not only safe but extremely versatile in its medical benefits. This has been reflected in the sales of legal cannabis products, which is expected to grow from $6.6 billion in 2016 to $24.1 billion in 2025.